Gastrointestinal tract involvement in mixed connective tissue disease (Sharp syndrome)

Czech version

Authors: Lenka Nosáková; Martin Schnierer; Peter Bánovčin; Katarína Stašková; Martin Uríček; Rudolf Hyrdel
Authors‘ workplace: Interná klinika – gastroenterologická JLF UK a UN Martin, Slovenská republika
Published in: Vnitř Lék 2020; 66(6): 53-57
Category: Case Report

Overview

Mixed connective tissue diseases (MCTD) is a very rare autoimmune disease connecting clinical signs of systemic lupus, systemic sclerosis, polymyositis and rheumatoid arthritis. Clinical manifestations are very diverse. In some patients, the digestive tract is affected in varying degrees. The esophagus is affected most often, and patients are complaining of dysphagia. Morphologically, this disorder is similar to the injure in systemic scleroderma. In this case, we describe a unique case of a severe damage of digestive tract manifested by esophageal motility disorders, cachectization, ascites, and repeated ileus conditions.

Keywords:

ascites – cachexia – esophageal motility disorders – mixed connective tissue disease

Sources

1. Gunnarsson R, Hetlevik SO, Lilleby V, et al. Mixed connective tissue disease. Best Pract Res Clin Rheumatol 2016; 30: 95–111.

2. Aringer M, Steiner G, Smolen JS. Does mixed connective tissue disease exist? Yes. Rheum Dis Clin North Am 2005; 31: 411–420.

3. Swanton J, Isenberg D. Mixed connective tissue disease: still crazy after all these years. Rheum Dis Clin North Am 2005; 31: 421–436.

4. Sharp GC MCTD: a concept which stood the test of time. Lupus 2002; 11: 333–339.

5. Marshall JB, Kretschmar JM, Gerhardt DC, et al. Gastrointestinal manifestations of mixed connective tissue disease. Gastroenterology 1990; 98: 1232–1238.

6. Gutierrez F, Valenzuela JE, Ehresmann GR, et al. Esophageal dysfunction in patients with mixed connective tissue diseases and systemic lupus erythematosus. Digestive Diseases and Sciences 1982; 27: 592–597.

7. Doria A, Bonavina L, Anselmino M, et al. Esophageal involvement in mixed connective tissue disease. Journal of Rheumatology 1991; 18: 685–690.

8. Fagundes MN, Caleiro MT, Navarro-Rodriguez T, et al. Esophageal involvement and interstitial lung disease in mixed connective tissue disease. Respiratory Medicine 2009; 103: 854–860.

9. Schneider HA, Yonker RA, Longley S, et al. Scleroderma esophagus: a nonspecific entity. Ann Intern Med 1984; 100: 848–850.

10. Nica AE, Alexa LM, Ionescu AO, et al. Esophageal disordes in mixed connective tissue diseases. J Med Life 2016; 9: 141–143.

11. Hyrdel R, Bánovčin P, Ďuríček M. Poruchy motility pažeráka – Chicagska klasifikácia, v 3.0. Gastroent Hepatol 2015; 69: 130–138.

12. Kroupa R, Dolina J, Hep A, et al. pH-metrie a manometrie jícnu. Současné postavení diagnostických metód. Čes a Slov Gastroent a Hepatol 2006; 60: 149–156.

13. Reichlin M. Problem in differentiating SLE and mixed connective-tissue disease. N Engl J Med 1976; 295: 1194–1195.

14. Kamataki A, Uzuki M, Sawai T. Histopathological Change of Esophagus related to Dysphagia in Mixed Connective Tissue Disease, Seminars in Dysphagia Renne Speyer and Hans Bogaardt, IntechOpen, DOI: 10.5772/60509. Available from: https: //www.intechopen.com/books/seminars-in-dysphagia/histopathological-change-of-esophagus-related-to-dysfagia-in-mixed-connective-tissue-disease.

15. Bennett RM, Spargo BH. Immune complex nephropathy in mixed connective tissue disease. Am J Med 1977; 63: 534–541.

16. Kitridou RC, Akmal M, Turkel SB, et al. Renal involvement in MCTD: a longitudinal clinicopathologic study. Semin Arthritis Rheum 1986; 16: 135–145.

17. Kobayashi S, Nagase M, Kimura M, et al. Renal involvement in mixed connective tissue disease. Am J Nephrol 1985; 5: 282–289.

18. Prakash MD, Luthra HS, Divertie MB. Intrathoracic manifestations in MCTD. Mayo Clin Proc 1985; 60: 813–821.